advertisement
Rigel Pharmaceuticals "sector perform," target price raised
07/09/09 - RBC Capital Markets
NEW YORK, July 9 (newratings.com) - Analysts at RBC Capital Markets reiterate their "sector perform" rating on Rigel Pharmaceuticals Inc (RIGL). The target price has been raised from $8 to $16.
Share Recommend this article to a friend
add RIGL to my stocks and get e-mail alerts on Rigel Pharmaceutical Inc.
News